Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

DRUG

Sitagliptin

Trial Locations (79)

23298

Medical College of Virginia, Richmond

Unknown

University of South Alabama Medical Center, Mobile

Anasazi Internal Medicine, Phoenix

University of Arkanasas for Medical Sciences, Little Rock

Office of William Zigrang, Burlingame

John Muir Clinical Research, Concord

Academic Medical Research Institute, Los Angeles

UCLA Medical Center, Los Angeles

Northern California Institute for Bone Health, Oakland

Dr. Wei Feng, Pasadena

Sierra Clinical Research - Orangevale, Roseville

Denver Nephrology PC, Denver

Western Nephrology & Metabolic Bone Disease PC, Lakewood

Western Nephrology & Metabolic Bone Disease PC, Westminster

Hartford Hospital, Hartford

Nephrology Associates of South Miami, Aventura

University of Florida Shands Hospital, Gainesville

Center for Diabetes & Endocrine Care, Hollywood

Jacksonville Center for Clinical Research, Jacksonville

Osler Medical Clinical Research, Melbourne

Tampa Bay Nephrology Associates, Tampa

Atlanta Diabetes Associates, Atlanta

Emory Clinic, Atlanta

University of Hawaii, Honolulu

Boise Kidney & Hypertension Institiute, Meridian

Iowa Diabetes & Endocrinology Research Center PLC, Des Moines

University of Iowa, Iowa City

Cray Diabetes Education Center, Kansas City

Cotton-O'Neil Diabetes & Endocrinology Center, Topeka

Dolby Research, LLC, Baton Rouge

Metabolic Center of Louisiana, Baton Rouge

Bruce Samuels LLC, Covington

Crescent City Clinical Research Center, Metairie

Egan Healthcare, Metairie

Arthritis and Diabetes Clinic, Monroe

Northwest Louisiana Nephrology Research, Shreveport

Joslin Diabetes Center at North Arundel Hospital, Glen Burnie

Biolab Research, LLC, Rockville

Genesys Integrated Group Practice, PC, Flint

Phillips Medical Services, PLLC, Jackson

Mississippi Medical Research, LLC, Picayune

Diabetes and Endocrinology Specialist, Inc, Chesterfield

Jefferson City Medical Group, Jefferson City

Arms, Dodge, Robinson, Wilber & Crouch, Inc., Kansas City

Washington U School of Medicine, St Louis

Platte Valley Medical Group, Kearney

Creighton Diabetes Center, Omaha

Creighton Nephrology, Omaha

UMDNJ-Robert Wood Johnson, New Brunswick

University of New Mexico Health Science Center, Albuquerque

Downstate University of Brooklyn, Brooklyn

HRRG, Orchard Park

Mayo Clinic Rochester, Rochester

SUNY - Upstate Medical University, Syracuse

Meritcare Medical Group, Fargo

Hightop Medical Research Center, Cincinnati

University of Cincinnati, Cincinnati

The Ohio State University Medical Center, Columbus

Willamette Valley Clinical Studies, Eugene

Lehigh Valley Hospital-Dept. of Medicine Research, Allentown

Thomas Jefferson University Hospital, Philadelphia

Renal Endocrine Associates, P. C., Pittsburgh

Aiken Center for Clinical Research, Aiken

Medical U of South Carolina, Charleston

SC Nephrology and Hyptertension Center, Inc., Orangeburg

Sumter Medical Specialists, Sumter

AM Diabetes and Endocrinology Center, Bartlett

Medical Nephrology Associates, Dyersburg

Dallas Diabetes & Endocrine Center, Dallas

North Texas Endocrine Center, Dallas

Texas Tech University Health Sciences, El Paso

Baylor Clinic (BCM 621), Houston

Baylor College of Medicine, Houston

Allied Institute of Medicine, San Antonio

Central Utah Clinic, American Fork

Clinical Research and Consulting Center, LLC, Fairfax

Medical College of Virginia, Richmond

Washington State University at Spokane, Spokane

UW Health - West, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00616811 - Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency | Biotech Hunter | Biotech Hunter